Successful treatment of recalcitrant generalized pustular psoriasis in a young child with interleukin-36 receptor antagonist mutation with secukinumab monotherapy
Generalized pustular psoriasis (GPP) is a severe, life-threatening form of psoriasis. Deficiency of interleukin (IL)-36 receptor antagonist has been found in a subset of patients with GPP, which is usually more difficult to treat with conventional treatment. We report a case of a 4-year-old Malaysia...
Saved in:
Main Authors: | Henrietta Albela (Author), Sabeera Begum (Author), Kin Fon Leong (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The utility of IL36RN mutation analysis in an elderly patient with generalized pustular psoriasis patient treated with secukinumab
by: Satoko Minakawa, et al.
Published: (2023) -
Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
by: Kazuhisa Furue, et al.
Published: (2017) -
Secukinumab in generalized pustular psoriasis
by: Shraddha Madanagobalane
Published: (2018) -
Successful treatment of juvenile generalized pustular psoriasis with secukinumab monotherapy. A case report and review of the literature
by: Raghavendra Rao, et al.
Published: (2022) -
Early-onset, severe prurigo nodularis in a young child with atopic dermatitis treated successfully with dupilumab
by: Henrietta Albela, et al.
Published: (2022)